Form D · Biotechnology
XDemics Corp
San Rafael, CA · CIK 0002026725
Offering snapshot reported Feb 6, 2026 · SEC filing
- Reported sold
- $7.4M Offering amount: $7.4M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Oct 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 6, 2026 | Initial | $7,399,999 | No comparison | 1 | SEC filing |
| Dec 5, 2024 | Initial | $5,543,624 | No comparison | 3 | SEC filing |
| Sep 13, 2024 | Amendment | $1,850,000 | $0vs Jul 23, 2024 | 1 | SEC filing |
| Jul 23, 2024 | Amendment | $1,850,000 | $0vs Jun 12, 2024 | 1 | SEC filing |
| Jun 12, 2024 | Initial | $1,850,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-572788
Source: Form D, filed Feb 6, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicole Bergman | Director |
| Colin Cook | Director |
| Christopher Thanos | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1281 Andersen Drive Suite K
San Rafael, CA, 94901
San Rafael, CA, 94901